Home> Products> effective symptom control

{ "products": [ { "_id": "6ad74702e53c888beeab308d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets", "description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n", "price": 210.0, "discountamount": 147.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2505, "imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:48:34.116Z", "updatedon": "2026-10-20T10:48:34.116Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 10", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad7442bf24c5a4bbccf4b10", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets", "description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.", "price": 230.0, "discountamount": 69.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2504, "imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T10:36:27.325Z", "updatedon": "2026-10-20T10:36:27.325Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN 3D 25", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6ad738866e5950566f21f588", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Ofloxacin & Dexamethasoneone Sodium Phosphate Eye/Ear Drops", "description": "CIPVISION ONLYAX DEXA Eye/Ear Drops is a pharmaceutical formulation containing Ofloxacin and Dexamethasone Sodium Phosphate. These ingredients perform complementary roles: Ofloxacin helps control infections caused by susceptible bacteria, while Dexamethasone Sodium Phosphate helps reduce inflammation. The combination may be prescribed for selected eye or ear conditions when both antibacterial treatment and inflammation control are clinically appropriate.\n\nIntended for ophthalmic and otic applications, CIPVISION ONLYAX DEXA should be used according to a qualified healthcare professional's instructions. The suitability of this formulation depends on the patient's diagnosis, medical history, and the approved product information.\n\nWith its defined composition and distinct brand identity, CIPVISION ONLYAX DEXA is a pharmaceutical product option for healthcare professionals, pharmacies, and medical distributors.\n\nComposition of CIPVISION ONLYAX DEXA Eye/Ear Drops\n\nCIPVISION ONLYAX DEXA contains two active pharmaceutical ingredients:\n\nOfloxacin: A fluoroquinolone antibiotic that works by interfering with bacterial enzymes required for DNA replication and repair. This action helps inhibit the growth of susceptible bacteria.\n\nDexamethasone Sodium Phosphate: A corticosteroid that suppresses inflammatory responses and helps reduce symptoms such as redness, swelling, and discomfort when steroid treatment is appropriate.\n\nThe exact strength, approved indications, and recommended dosage should always be checked on the product packaging and prescribing information.\n\nKey Features of CIPVISION ONLYAX DEXA\n\nThe formulation combines antibacterial and anti-inflammatory properties in one topical product.\n\nDual-ingredient formulation: Combines an antibiotic with a corticosteroid.\n\nAntibacterial action: Ofloxacin targets susceptible bacteria when used for an appropriate indication.\n\nInflammation control: Dexamethasone Sodium Phosphate helps manage inflammatory symptoms.\n\nTopical application: Intended for eye or ear use according to the approved product labelling.\n\nProfessional supervision: Requires appropriate clinical assessment and guidance for safe use.\n\nThe suitability of these features depends on the diagnosed condition and whether both ingredients are necessary for treatment.\n\nWhat Is CIPVISION ONLYAX DEXA Used For?\n\nCIPVISION ONLYAX DEXA may be prescribed for certain bacterial eye or ear conditions accompanied by inflammation. A healthcare professional must determine whether this combination is appropriate for the specific diagnosis.\n\nOphthalmic Applications\n\nWhen indicated by the approved product label, an Ofloxacin and Dexamethasone formulation may be used for selected bacterial eye conditions associated with inflammation.\n\nOfloxacin helps address susceptible bacterial pathogens, while Dexamethasone Sodium Phosphate helps control the inflammatory response. However, eye redness, watering, itching, and pain can result from allergies, viral infections, fungal infections, or other disorders. These conditions may require different treatments.\n\nA proper eye examination is important before using antibiotic-corticosteroid drops.\n\nOtic Applications\n\nFor selected ear conditions, an appropriate antibiotic and corticosteroid combination may be prescribed when bacterial infection and inflammation occur together.\n\nSymptoms such as ear pain, discharge, swelling, and itching can have different causes. The choice of treatment depends on the site of infection, the condition of the eardrum, and the product's approved indications.\n\nUse CIPVISION ONLYAX DEXA in the ear only when the prescribing information permits it and a healthcare professional recommends its use.\n\nHow Does CIPVISION ONLYAX DEXA Work?\n\nThe two active ingredients act through different mechanisms.\n\nOfloxacin: This antibiotic inhibits bacterial enzymes called DNA gyrase and topoisomerase IV. These enzymes are essential for bacterial DNA replication and repair. Interfering with these processes helps prevent susceptible bacteria from multiplying.\n\nDexamethasone Sodium Phosphate: This corticosteroid reduces inflammatory activity in affected tissues. It helps control inflammation and associated symptoms when corticosteroid treatment is medically appropriate.\n\nTogether, these ingredients provide antibacterial and anti-inflammatory effects in selected conditions. However, corticosteroids may mask signs of infection or worsen certain untreated infections. Therefore, this combination should only be used for an appropriate diagnosis under medical supervision.\n\nPotential Benefits of CIPVISION ONLYAX DEXA\n\nThe potential benefits depend on the patient's condition and the clinical suitability of the formulation.\n\nCombined treatment approach: Offers an antibiotic and an anti-inflammatory ingredient in one formulation.\n\nTargeted antibacterial activity: Ofloxacin acts against susceptible bacteria.\n\nInflammation management: Dexamethasone Sodium Phosphate helps reduce inflammation.\n\nLocal administration: Drops allow topical application when suitable for the diagnosed condition.\n\nSupport for prescribed treatment: May be included in a healthcare professional's treatment plan for selected eye or ear conditions.\n\nThis product is not suitable for every infection. Its effectiveness depends on the cause of the condition, bacterial susceptibility, correct administration, and adherence to the prescribed treatment.\n\nHow to Use CIPVISION ONLYAX DEXA Eye/Ear Drops\n\nUse CIPVISION ONLYAX DEXA according to your doctor's instructions and the product label.\n\nWash your hands: Clean your hands before handling the bottle or administering the drops.\n\nCheck the product: Confirm the product name, expiry date, and instructions before use.\n\nAvoid contamination: Do not allow the dropper tip to touch your eye, ear, fingers, or other surfaces.\n\nFollow the prescribed dose: Use only the number of drops and the frequency recommended by your healthcare professional.\n\nComplete the prescribed course: Do not stop, extend, or repeat treatment without medical advice.\n\nAvoid sharing: Never share the bottle with another person, as this can spread infection.\n\nStore correctly: Follow the storage and after-opening instructions printed on the packaging.\n\nFor eye administration, ask your healthcare professional about contact lens precautions. For ear administration, seek advice before use if you have had ear surgery, have ear tubes, or may have a perforated eardrum.\n\nPrecautions and Safety Information\n\nCIPVISION ONLYAX DEXA should be used only when clinically indicated. Its antibiotic and corticosteroid components may not be appropriate for every patient or type of infection.\n\nProlonged use: Extended or inappropriate corticosteroid use may increase eye pressure, contribute to glaucoma or cataracts, and delay tissue healing.\n\nInfection risks: Corticosteroids may mask symptoms or worsen certain viral, fungal, or untreated infections.\n\nAllergies: Inform your healthcare professional about any previous reaction to Ofloxacin, Dexamethasone, or related ingredients.\n\nExisting conditions: Disclose any history of glaucoma, eye disease, ear problems, or ear surgery before treatment.\n\nOther medicines: Tell your doctor about other prescription medicines and eye or ear preparations you are using.\n\nPregnancy and breastfeeding: Seek medical advice before using the product during pregnancy or while breastfeeding.\n\nWorsening symptoms: Obtain prompt medical assessment if symptoms persist, worsen, or return after treatment.\n\nSeek urgent medical attention for severe eye pain, sudden changes in vision, significant hearing changes, or other serious symptoms.\n\nDo not use the product after its expiry date. Follow the packaging instructions for storage and disposal after opening.\n\nWhy Is CIPVISION ONLYAX DEXA Relevant to Pharmaceutical Product Portfolios?\n\nCIPVISION ONLYAX DEXA combines two established pharmaceutical ingredients in a topical formulation intended for selected conditions involving bacterial infection and inflammation. Its defined composition and identifiable brand make it relevant to pharmaceutical catalogues and product information resources.\n\nFor pharmacies, distributors, healthcare professionals, and pharmaceutical websites, clear product information helps communicate the formulation's intended use, precautions, and administration requirements. Accurate product descriptions should always reflect the approved label rather than imply that the formulation is suitable for every eye or ear complaint.\n\nConclusion\n\nCIPVISION ONLYAX DEXA Eye/Ear Drops contains Ofloxacin and Dexamethasone Sodium Phosphate, combining antibacterial activity with anti-inflammatory action. It may be prescribed for selected eye or ear conditions when both components are clinically appropriate.\n\nUnderstanding the composition, intended applications, administration precautions, and potential risks supports responsible use. Always consult a qualified healthcare professional and refer to the approved product packaging for the exact strength, indications, contraindications, and directions for use.\n\nFrequently Asked Questions (FAQs)\n\n1. What is CIPVISION ONLYAX DEXA Eye/Ear Drops?\n\nCIPVISION ONLYAX DEXA is a pharmaceutical formulation containing Ofloxacin, an antibiotic, and Dexamethasone Sodium Phosphate, a corticosteroid. It is intended for selected conditions as directed by a healthcare professional.\n\n2. What is the composition of CIPVISION ONLYAX DEXA?\n\nThe stated active ingredients are Ofloxacin and Dexamethasone Sodium Phosphate. Refer to the product packaging to confirm their exact strengths and the approved formulation details.\n\n3. What is CIPVISION ONLYAX DEXA used for?\n\nIt may be prescribed for certain bacterial eye or ear conditions associated with inflammation when an antibiotic-corticosteroid combination is appropriate.\n\n4. Can CIPVISION ONLYAX DEXA be used without medical advice?\n\nNo. Medical guidance is important because the corticosteroid component may worsen certain infections or be unsuitable for particular eye and ear conditions.\n\n5. How should CIPVISION ONLYAX DEXA be stored?\n\nFollow the storage instructions printed on the product packaging. Keep the bottle tightly closed as directed, protect it from unsuitable storage conditions, and keep it out of children's reach.\n\n6. Can CIPVISION ONLYAX DEXA be used for every type of eye or ear infection?\n\nNo. Different infections and inflammatory conditions require different treatments. A healthcare professional should identify the cause of the symptoms and confirm whether this formulation is appropriate.", "price": 50.0, "discountamount": 15.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2502, "imageuri": "https://productimages.withfloats.com/actual/6ad73887063777c0e22d5809.png", "tileimageuri": "https://productimages.withfloats.com/tile/6ad73887063777c0e22d5809.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-20T09:46:46.02Z", "updatedon": "2026-10-20T09:46:46.02Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//ofloxacin-dexamethasoneone-sodium-phosphate-eye-ear-drops/2502", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION ONLYAX DEXA", "category": "Opthalmology Range", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a952bdada41ea9aeeec5e4a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide injection 8 mg", "description": "The semaglutide injection, 8 mg, contains a total of 8 mg of semaglutide, a long-acting GLP-1 receptor agonist. It is used under medical supervision as part of treatment for appropriate adults with type 2 diabetes mellitus and, depending on the specific approved product and indication, for cardiovascular risk reduction and chronic weight management.\n1. Product Overview & Specifications\nAn 8 mg/3 mL semaglutide pen contains 8 mg of the active medicine in a 3 mL delivery system. When specifically designed to provide 2 mg per weekly dose, the total quantity can provide four 2 mg doses.\nActive Ingredient: Semaglutide\nTotal Strength: 8 mg\nExample Presentation: 8 mg/3 mL multi-dose pen\nDrug Class: GLP-1 receptor agonist\nRoute: Subcutaneous injection\nCommon Injection Areas: Abdomen, thigh, or upper arm\nAdministration: Once weekly, according to the prescribed schedule\nMechanism of Action\nSemaglutide mimics the activity of the naturally occurring hormone GLP-1 (glucagon-like peptide-1). It acts on GLP-1 receptors involved in blood-glucose regulation, digestion, and appetite.\nImproves glucose-dependent insulin release: Semaglutide encourages the pancreas to release insulin when blood glucose levels are elevated.\nReduces glucagon secretion: It lowers inappropriate glucagon release, helping reduce the amount of glucose produced by the liver.\nSlows gastric emptying: Semaglutide can delay the movement of food from the stomach, contributing to prolonged fullness.\nReduces appetite: Its effects on appetite-regulating pathways in the brain can decrease hunger and food intake.\n2. Primary Indications & Uses\nSemaglutide may be prescribed for several clinically established purposes depending on the specific formulation, approved labeling, and patient's medical condition.\nType 2 Diabetes Management\nSemaglutide can be used alongside appropriate diet and physical activity to improve blood-glucose control in adults with type 2 diabetes.\nCardiovascular Risk Reduction\nIn eligible adults with type 2 diabetes and established cardiovascular disease, certain semaglutide products have demonstrated a reduction in the risk of major cardiovascular events, including cardiovascular death, non-fatal heart attack, and non-fatal stroke.\nKidney Disease\nCertain semaglutide formulations and indications have demonstrated kidney-related benefits in specific populations. The appropriate product and indication should be determined by a healthcare professional.\nChronic Weight Management\nSemaglutide is also used for long-term weight management in eligible adults with obesity or overweight accompanied by weight-related health conditions, depending on the approved formulation and local prescribing guidance.\n3. Key Benefits of Semaglutide 8 mg Therapy\nClinical Area\nPotential Therapeutic Role\nBlood-Glucose Control\nHelps lower elevated blood glucose and improve glycemic control in appropriate patients.\nWeight Management\nReduces appetite and food intake, supporting sustained weight reduction when prescribed for this purpose.\nCardiovascular Health\nCertain approved semaglutide indications can reduce major cardiovascular event risk in eligible patients.\nMetabolic Support\nInfluences glucose regulation, appetite, insulin secretion, and glucagon activity.\nWeekly Administration\nA once-weekly injection can provide a convenient treatment schedule when prescribed.\n\n4. Side Effects & Safety Warnings\nCommon Adverse Reactions\nDigestive symptoms are among the most frequently reported adverse effects, particularly when treatment is initiated or the dose is increased.\nPossible side effects include:\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort\nBloating\nBelching\nIndigestion or heartburn\nReduced appetite\nThese effects may improve as the body becomes accustomed to treatment.\nFrequently Asked Questions\n1. How much weight can you lose with semaglutide?\nWeight reduction varies significantly between individuals and depends on the prescribed formulation, dose, treatment duration, diet, physical activity, and adherence. Clinical trials of approved weight-management regimens have demonstrated substantial average percentage weight loss over extended treatment periods.\n2. How much is 8 units of semaglutide in mL?\nOn a U-100 insulin syringe, 100 units corresponds to 1 mL, so 8 units corresponds to 0.08 mL. However, this conversion only describes syringe volume. It does not determine the amount of semaglutide in mg because the medication concentration varies between products. Always verify the exact concentration before measuring any dose.\n3. Is semaglutide injection safe for weight loss?\nSemaglutide can be an effective treatment for weight management when an approved formulation is prescribed to an eligible patient and used under appropriate medical supervision. It has important contraindications and warnings, including risks involving the gastrointestinal system, gallbladder, pancreas, kidneys, and thyroid C-cell tumors.\n4. How many mg of semaglutide are used for weight loss?\nThe appropriate dose depends on the specific semaglutide product. Weight-management treatment commonly begins with a lower dose and is gradually increased to a maintenance dose to improve tolerability. The maintenance dose should be determined according to the product's approved prescribing information and the healthcare professional's instructions.\n5. How much weight can I lose in 2 months with semaglutide?\nThere is no guaranteed amount of weight loss during the first two months. Individual results vary because treatment generally begins at a lower dose and is increased gradually. Diet, physical activity, starting weight, medical conditions, and adherence also affect the result.\n6. What happens when you stop semaglutide?\nAfter discontinuation, semaglutide gradually leaves the body. Appetite and food intake may increase as its effects decrease, and some people regain weight. Maintaining healthy eating and physical activity habits may help support weight management after treatment, but discontinuation should be discussed with a healthcare professional.\n7. How long does an 8 mg/3 mL semaglutide pen last?\nIf a specific 8 mg/3 mL pen is designed to deliver 2 mg per weekly dose, it contains four 2 mg doses and therefore provides approximately four weeks of treatment. The actual duration depends on the specific device and prescribed dosing instructions.\n8. What is semaglutide injection 8 mg used for?\nSemaglutide is used for approved indications such as improving blood-glucose control in type 2 diabetes and, depending on the formulation, supporting chronic weight management and reducing cardiovascular risk in eligible patients.\n9. What foods should be avoided while taking semaglutide?\nLarge, high-fat, greasy, or fried meals may worsen gastrointestinal symptoms such as nausea, bloating, and reflux. Smaller meals and balanced food choices may be easier to tolerate. Alcohol intake should also be discussed with a healthcare professional.\n10. Can you eat bananas while taking semaglutide?\nYes, bananas can generally be included in a balanced diet while using semaglutide. Portion size should be considered as part of an individual's overall calorie and carbohydrate intake, particularly for people managing diabetes.\n11. What is the best time of day to inject semaglutide?\nSemaglutide injections can generally be administered at any time of day, with or without meals, depending on the specific product instructions. The injection should be taken on the same day each week as prescribed.\n12. Will I lose weight during the first week of semaglutide?\nSome people may notice an early change in appetite or body weight, while others may not see a significant difference initially. Early treatment doses are generally introduced gradually to help the body adjust rather than to produce immediate maximum weight loss.\n13. How quickly does semaglutide start lowering blood sugar?\nSemaglutide begins acting after administration, but the degree and timing of blood-glucose improvement vary. Significant treatment effects develop progressively, particularly as the prescribed dose is gradually adjusted.\n14. What should I do if I miss a semaglutide dose?\nThe correct missed-dose procedure depends on the specific semaglutide product. Follow the instructions supplied with your prescribed product. Do not take an extra dose to compensate for a missed injection.\n15. Where is the best place to inject semaglutide?\nSemaglutide is administered subcutaneously. Common injection sites include the abdomen, front of the thigh, or upper arm, according to the product instructions. Rotating injection locations can help reduce repeated irritation at one site.\nConclusion\nSemaglutide injection 8 mg contains semaglutide, a long-acting GLP-1 receptor agonist that influences blood-glucose regulation, glucagon secretion, gastric emptying, and appetite. Depending on the specific formulation and approved indication, semaglutide may be used for type 2 diabetes management, chronic weight management, and cardiovascular risk reduction in eligible patients.\nAn 8 mg/3 mL presentation designed for 2 mg weekly dosing can provide four weekly doses. However, semaglutide concentrations, pen designs, approved doses, and indications can differ between products. Treatment should therefore follow the exact product instructions and a healthcare professional's prescription.", "price": 7800.0, "discountamount": 2340.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2498, "imageuri": "https://productimages.withfloats.com/actual/6a952bdd8359c1b7edbc7468.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a952bdd8359c1b7edbc7468.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-31T07:23:06.814Z", "updatedon": "2026-08-31T07:23:06.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//semaglutide-injection-8-mg/2498", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 8MG", "category": "DIABETIC RANGE", "tags": [ "Semaglutide injection 8 mg", "semaglutide injection 8 mg", "semaglutide 8 mg injection uses", "semaglutide 8 mg injection benefits", "semaglutide 8 mg injection dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a86e496cc4491de1ed77dfd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Etoricoxib & Cyclobenzaprine Hydrochloride Tablets", "description": "ERITOCOX BENZ 90/5 is a fixed-dose combination tablet pairing Etoricoxib 90 mg, a selective COX-2 anti-inflammatory, with Cyclobenzaprine Hydrochloride 5 mg, a centrally acting muscle relaxant. It is prescribed for short-term relief of acute musculoskeletal problems where pain, swelling, and muscle tightness occur together — think a sudden low-back strain, a stiff neck, or a flare-up of arthritis where the surrounding muscles clamp down defensively. Rather than treating the inflammation alone or the spasm alone, this tablet addresses both mechanisms in one dose, which can mean fewer pills and a more complete response for short, acute episodes. It is a prescription-only (Schedule H) medicine, produced under WHO-GMP and ISO-certified manufacturing standards by Steris Healthcare Pvt. Ltd. Typical side effects include drowsiness, dry mouth, and mild stomach upset; because the combination carries cardiovascular, gastrointestinal, and kidney considerations, it should only be used under a doctor's supervision. This page walks through what the tablet does, how it works, correct usage, safety information, and answers to the questions people most often ask.\n\nWhat Is ERITOCOX BENZ 90/5?\n\nPain from an acute back injury, a wrenched neck, or an arthritis episode almost never travels alone — it tends to bring a tense, guarded muscle along with it that makes every movement feel worse. ERITOCOX BENZ 90/5 was formulated with that pattern in mind, folding two separate mechanisms into a single tablet rather than requiring two prescriptions.\n\nActive Ingredient\tStrength\tRole\nEtoricoxib\t90 mg\tSelective COX-2 inhibitor for inflammatory pain\nCyclobenzaprine Hydrochloride\t5 mg\tCentrally acting skeletal muscle relaxant\n\nEach tablet is manufactured by Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO-certified pharmaceutical company, so every batch meets verified potency and quality benchmarks.\n\nWhy This Combination Makes Sense\n\nMusculoskeletal pain is rarely a single-track problem. When tissue is injured or irritated, inflammation flares up locally — and nearby muscles frequently respond by tightening protectively. That protective tightening, the spasm, often becomes a pain generator of its own. Treat only the inflammation and the spasm can linger; treat only the spasm and the underlying inflammation keeps driving discomfort.\n\nERITOCOX BENZ 90/5 is built to intervene on both fronts at once:\n\nEtoricoxib addresses the chemical cascade responsible for pain and swelling at the injured site.\nCyclobenzaprine works through the central nervous system to calm the muscle guarding that so often rides alongside that pain.\nMechanism of Action: How ERITOCOX BENZ 90/5 Works\n\nEtoricoxib selectively inhibits the COX-2 enzyme — the enzyme the body ramps up at sites of tissue damage or irritation to manufacture prostaglandins, the chemical messengers behind pain, swelling, and localized heat. Because it targets COX-2 specifically rather than blocking both COX-1 and COX-2 the way older, non-selective NSAIDs do, etoricoxib is designed to control inflammatory pain while leaving more of the COX-1 activity that protects the stomach lining relatively undisturbed.\n\nCyclobenzaprine Hydrochloride takes a different route entirely — its primary site of action is the brainstem, not the muscle fiber itself. By dampening excessive motor signaling sent to skeletal muscle, it reduces spasm and stiffness without producing the broad muscle weakness that a directly-acting muscle agent might cause.\n\nPut together, the tablet delivers a two-pronged effect: peripheral anti-inflammatory action from etoricoxib, layered with central muscle relaxation from cyclobenzaprine.\n\n[Reviewer placeholder: insert verified pharmacokinetic data (onset, half-life, bioavailability) once confirmed by medical/regulatory team — do not publish unverified figures.]\n\nClinical Uses of ERITOCOX BENZ 90/5\n\nA physician may prescribe this combination for short-term management of acute conditions where pain, inflammation, and spasm show up together, including:\n\nCondition\tTypical Presentation\nAcute lower back pain\tPain with associated muscle guarding/spasm\nNeck strain / cervical spasm\tStiff, restricted neck movement\nSprains, strains, overuse injuries\tMusculoskeletal trauma with inflammatory pain\nOsteoarthritis flare-ups\tJoint pain accompanied by surrounding muscle tightness\nPostural or occupational muscle pain\tWork- or posture-related inflammation and tension\nMovement restriction linked to spasm\tReduced range of motion driven by muscular guarding\n\nSuitability for any of the above must be confirmed by a doctor based on your specific diagnosis and medical history.\n\nKey Benefits of ERITOCOX BENZ 90/5\nOne tablet, two mechanisms — anti-inflammatory pain relief and muscle-spasm relief combined, simplifying an otherwise two-drug regimen.\nSite-focused inflammation control — etoricoxib's COX-2 selectivity is intended to concentrate its effect where inflammation is actually active.\nA comparatively gentler GI footprint — COX-2-selective action is generally linked to lower gastrointestinal irritation risk than older non-selective NSAIDs, though vigilance is still warranted.\nLoosens spasm-related stiffness — cyclobenzaprine's central action helps release tight, guarded muscles restricting movement.\nAids functional recovery — easing both pain and spasm can make it more realistic to resume light activity, stretching, or physiotherapy once your doctor clears you.\nStreamlined short-course dosing — a once-daily schedule (as prescribed) cuts down pill burden versus taking an NSAID and a muscle relaxant separately.\nDosage & Administration\n\nThe following is general reference information — your doctor's specific prescription always takes precedence.\n\nTake ERITOCOX BENZ 90/5 exactly as prescribed, generally once a day, with or without food.\nSwallow the tablet whole with water; avoid crushing or chewing unless your doctor tells you otherwise.\nTreatment is typically short — anywhere from a few days to roughly two weeks — reflecting the acute, self-limiting nature of most pain-and-spasm episodes.\nIf a dose is missed, take it as soon as you remember, but skip it entirely if the next dose is nearly due. Never double up to make up for a missed dose.\nDo not extend the treatment period or adjust your dose independently, even if symptoms haven't fully resolved.\nSide Effects of ERITOCOX BENZ 90/5\nCommon Side Effects\nDrowsiness or sleepiness\nDizziness\nDry mouth\nHeadache\nStomach discomfort or indigestion\nNausea\nFatigue\nMild elevation in blood pressure in some individuals\nSerious Side Effects — Seek Medical Help Promptly\nSigns of gastrointestinal bleeding, such as black stools or vomiting blood\nA severe allergic reaction — swelling of the face or throat, breathing difficulty, or widespread rash\nChest pain, irregular heartbeat, or other symptoms suggestive of a cardiovascular event\nYellowing of the skin or eyes, which may point to liver involvement\nA noticeable drop in urine output, which may suggest kidney impairment\nSevere dizziness, confusion, or fainting\n\nIf any of these serious symptoms appear, stop the medicine and get medical attention immediately.\n\nPrecautions & Warnings\nShare your full medical history with your doctor before starting, including any heart, kidney, or liver conditions.\nUse cautiously — or avoid altogether — if you have a history of stomach ulcers or gastrointestinal bleeding.\nGenerally not advised for people with uncontrolled high blood pressure, existing heart disease, or a prior stroke, unless a doctor specifically clears its use.\nSteer clear of alcohol, since it can amplify cyclobenzaprine's sedative effect and add to gastrointestinal risk.\nCyclobenzaprine may cause drowsiness or dizziness — hold off on driving or operating machinery until you know how the tablet affects you.\nDon't combine ERITOCOX BENZ 90/5 with other NSAIDs, painkillers, or sedating medicines without checking with your doctor first.\nAvoid the medicine if you have known hypersensitivity to etoricoxib, cyclobenzaprine, or related compounds.\nNot generally recommended during pregnancy or breastfeeding unless a doctor specifically advises otherwise.\nAvoid combining with MAO inhibitors, or using shortly after stopping them.\nDrug Interactions to Flag With Your Doctor\n\nDisclose every prescription medicine, over-the-counter product, and supplement you take. Extra caution is needed around medicines affecting:\n\nBlood pressure regulation\nKidney function\nBlood clotting\nCentral nervous system activity (sedatives, other muscle relaxants)\nLiver metabolism\nOther anti-inflammatory or pain-relief medicines\nConclusion\n\nERITOCOX BENZ 90/5 brings Etoricoxib 90 mg and Cyclobenzaprine Hydrochloride 5 mg together to tackle a problem that rarely presents as a single issue — pain, inflammation, and muscle spasm that reinforce one another in acute musculoskeletal conditions. By acting on both the inflammatory and muscular sides of that cycle, it offers a more rounded short-term response than either ingredient could provide alone.\n\nGiven the genuine cardiovascular, gastrointestinal, kidney, and central-nervous-system considerations involved, ERITOCOX BENZ 90/5 is meant strictly for short, doctor-supervised courses — not casual or extended self-treatment. Always check with your doctor to confirm whether this combination is right for your condition, medical history, and current medications.\n\nPrescription only – consult your doctor.\n\nFrequently Asked Questions (Google & AI Mode / Voice Search Optimized)\n\n1. What is ERITOCOX BENZ 90/5 used for? It's typically prescribed for short-term relief of acute musculoskeletal issues — such as back pain, neck strain, or an arthritis flare-up — where pain, inflammation, and muscle spasm show up together.\n\n2. Is ERITOCOX BENZ 90/5 a muscle relaxant? It's a combination tablet: the muscle-relaxing effect comes from its Cyclobenzaprine Hydrochloride component, while Etoricoxib supplies the pain-relieving, anti-inflammatory action.\n\n3. Is Etoricoxib a strong painkiller? Etoricoxib is an effective selective COX-2 inhibitor typically used for moderate inflammation-related pain, such as arthritis or an acute musculoskeletal injury. Its appropriateness for your level of pain should be assessed by a doctor.\n\n4. Is Etoricoxib safe for the kidneys? As with other NSAIDs, etoricoxib can influence kidney function, particularly with extended use, higher doses, dehydration, or existing kidney disease. It should be used carefully and only under medical guidance if kidney health is a concern.\n\n5. Should ERITOCOX BENZ 90/5 be taken in the morning or at night? It's usually taken once a day at a time your doctor sets. Since cyclobenzaprine can cause drowsiness, many doctors lean toward an evening dose — but always stick to your specific prescription.\n\n6. What are the common side effects of ERITOCOX BENZ 90/5? Frequently reported effects include drowsiness, dizziness, dry mouth, headache, stomach discomfort, and mild fatigue. Most fade on their own, but persistent symptoms should be reported to your doctor.\n\n7. How fast does ERITOCOX BENZ 90/5 start working? Etoricoxib tends to absorb fairly quickly, and many people feel pain relief within roughly an hour, though onset can vary by individual and whether the tablet is taken with food.\n\n8. What should be avoided while on ERITOCOX BENZ 90/5? Skip alcohol, avoid taking other NSAIDs or painkillers without medical advice, and hold off on driving or operating machinery if you're feeling drowsy or dizzy.\n\n9. How many days can ERITOCOX BENZ 90/5 be taken? It's usually prescribed for a short stretch — a few days up to around two weeks — matching how acute conditions typically resolve. Anything longer needs your doctor's review.\n\n10. What are the benefits of ERITOCOX BENZ 90/5? It delivers combined relief from pain, inflammation, and muscle spasm in one tablet, which can make it easier to move normally and get back to daily activity sooner when used as directed.\n\n11. How safe is ERITOCOX BENZ 90/5? Taken exactly as prescribed and for the recommended duration, it's generally considered safe for most adults. It does carry cardiovascular, gastrointestinal, kidney, and liver-related risks that call for medical supervision, especially if you already have related conditions.\n\n12. Can ERITOCOX BENZ 90/5 be used for knee pain? Yes — its etoricoxib component is commonly used for joint pain tied to osteoarthritis or an acute injury, including the knee, by reducing the underlying inflammation. A doctor should confirm suitability first.\n\n13. Does ERITOCOX BENZ 90/5 cause drowsiness? Yes — drowsiness and dizziness are known effects linked to its cyclobenzaprine component. Avoid driving or tasks requiring full alertness until you know how it affects you.\n\n14. Can ERITOCOX BENZ 90/5 be bought without a prescription? No. This is a prescription-only medicine meant to be taken solely under a qualified doctor's supervision — it isn't meant for self-prescribing or extended use without medical oversight.\n\n15. Can ERITOCOX BENZ 90/5 be taken with food? It can generally be taken with or without food, though taking it with food may ease stomach discomfort for some people. Follow your doctor's specific instructions.\n\n16. Is ERITOCOX BENZ 90/5 habit-forming? Cyclobenzaprine isn't considered addictive with typical short-term use, but the tablet should still be taken only for the prescribed duration and not restarted on your own without medical advice.\n\n17. Who should avoid taking ERITOCOX BENZ 90/5? People with active stomach ulcers, significant heart, kidney, or liver disease, known hypersensitivity to NSAIDs, or those who are pregnant or breastfeeding should avoid it unless a doctor specifically clears its use.", "price": 222.0, "discountamount": 67.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2495, "imageuri": "https://productimages.withfloats.com/actual/6a86e4990f089c4695c57658.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a86e4990f089c4695c57658.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-20T11:27:18.403Z", "updatedon": "2026-08-20T11:27:18.403Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//etoricoxib-cyclobenzaprine-hydrochloride-tablets/2495", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ERITOCOX BENZ 90/5", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a6dedd85b0d81b5d5e65e09", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Olanzapine Mouth Dissolving Tablets 2.5 mg", "description": "OLANZPRIME 2.5 is a high-quality pharmaceutical formulation containing Olanzapine 2.5 mg in a convenient mouth dissolving tablet (MDT) dosage form. Developed to support the management of various psychiatric disorders, this formulation is designed to deliver effective therapy while improving patient convenience and treatment adherence. Manufactured in GMP-certified facilities using premium pharmaceutical ingredients, OLANZPRIME 2.5 is produced under strict quality control standards to ensure safety, purity, and consistent performance.\n\nThe rapidly dissolving tablet is formulated to disintegrate quickly on the tongue without the need for water, making it an ideal option for patients who have difficulty swallowing conventional tablets. Its user-friendly dosage form enhances ease of administration while providing dependable therapeutic support under the supervision of a qualified healthcare professional.\n\nComposition\n\nBrand Name: OLANZPRIME 2.5\n\nGeneric Name: Olanzapine\n\nStrength: 2.5 mg\n\nDosage Form: Mouth Dissolving Tablet (MDT)\n\nWhat is OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 contains Olanzapine, an atypical antipsychotic medication that works by regulating the activity of important neurotransmitters such as dopamine and serotonin. By helping restore the balance of these chemical messengers, the medicine supports improved emotional stability, clearer thinking, better behavioral control, and overall mental health.\n\nIts mouth dissolving formulation is specifically designed to provide greater convenience, particularly for individuals who experience difficulty swallowing standard oral tablets.\n\nUses of OLANZPRIME 2.5\n\nOLANZPRIME 2.5 may be recommended by healthcare professionals for the treatment and long-term management of various psychiatric conditions, including:\n\nSchizophrenia\nBipolar disorder, including manic and mixed episodes\nMaintenance therapy for bipolar disorder\nManagement of psychotic symptoms\nSelected behavioral or psychiatric conditions as determined by a physician\n\nThe appropriate dosage and duration of therapy should always be decided by a qualified healthcare provider based on the patient's individual clinical needs.\n\nBenefits of OLANZPRIME 2.5\nQuick-Dissolving Technology\n\nThe tablet dissolves rapidly in the mouth without requiring water, making administration simple and convenient.\n\nImproved Patient Adherence\n\nThe easy-to-take formulation is especially beneficial for elderly patients and individuals with swallowing difficulties, helping improve compliance with prescribed treatment.\n\nProven Antipsychotic Therapy\n\nOlanzapine is a well-established atypical antipsychotic used by healthcare professionals to help manage symptoms associated with schizophrenia and bipolar disorder.\n\nManufactured to High Pharmaceutical Standards\n\nProduced under strict GMP guidelines, OLANZPRIME 2.5 undergoes comprehensive quality testing to ensure consistent safety, efficacy, and product reliability.\n\nConvenient Anytime Administration\n\nThe mouth dissolving dosage form offers flexibility and ease of use, even when drinking water is not readily available.\n\nHow OLANZPRIME 2.5 Works\n\nOlanzapine belongs to the atypical antipsychotic class of medicines. It acts by modulating the activity of dopamine and serotonin receptors in the brain, helping restore a healthy balance of neurotransmitters involved in mood, perception, and behavior.\n\nThis therapeutic action may help reduce symptoms such as:\n\nHallucinations\nDelusional thoughts\nAgitation\nMood fluctuations\nDisorganized thinking\nAnxiety associated with certain psychiatric conditions\n\nWith regular use as prescribed, OLANZPRIME 2.5 helps support mental stability and improves overall quality of life for many patients.\n\nDosage and Administration\n\nTake OLANZPRIME 2.5 exactly as directed by your healthcare professional.\n\nGeneral administration guidelines include:\n\nPlace the tablet directly on the tongue.\nAllow it to dissolve completely before swallowing.\nWater is generally not required.\nTake the medication at the same time each day whenever possible.\nContinue treatment for the duration recommended by your physician.\nDo not stop taking the medicine without medical advice.\nPossible Side Effects\n\nLike all prescription medicines, OLANZPRIME 2.5 may cause side effects in some individuals, although not everyone experiences them.\n\nCommon side effects may include:\n\nDrowsiness\nDizziness\nDry mouth\nIncreased appetite\nWeight gain\nConstipation\nTiredness\n\nSerious or unusual symptoms require prompt medical evaluation. Always consult your healthcare provider if side effects become persistent or concerning.\n\nPrecautions and Warnings\n\nBefore starting OLANZPRIME 2.5, inform your healthcare provider if you have:\n\nDiabetes mellitus\nLiver disorders\nHeart disease\nEpilepsy or seizure disorders\nHigh cholesterol or lipid abnormalities\nHistory of stroke\nKidney impairment\nKnown allergy to Olanzapine or any ingredient in the formulation\n\nAlcohol consumption should generally be avoided during treatment, as it may increase drowsiness and other central nervous system effects.\n\nStorage Instructions\n\nTo preserve product quality:\n\nStore in a cool and dry place.\nProtect from direct sunlight and excessive moisture.\nKeep below the storage temperature mentioned on the product packaging.\nStore in the original blister pack until use.\nKeep out of the reach of children.\nWhy Choose OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 combines trusted antipsychotic therapy with the convenience of mouth dissolving technology, making it an excellent option for patients who require easy administration without compromising treatment effectiveness.\n\nKey Advantages\n\nPremium-quality Olanzapine 2.5 mg formulation\nRapid mouth dissolving tablet for easy administration\nNo water required for consumption\nSupports improved medication compliance\nManufactured under stringent GMP quality standards\nReliable dosage accuracy and product consistency\nSecure packaging designed to maintain product stability\nFrequently Asked Questions (FAQs)\nWhat is OLANZPRIME 2.5 prescribed for?\n\nOLANZPRIME 2.5 is prescribed for the treatment and management of schizophrenia, bipolar disorder, and other psychiatric conditions as determined by a qualified healthcare professional.\n\nDoes this tablet need to be taken with water?\n\nNo. The mouth dissolving tablet is designed to dissolve on the tongue, allowing convenient administration without water.\n\nCan I discontinue OLANZPRIME 2.5 without consulting my doctor?\n\nNo. Treatment should not be stopped suddenly, as abrupt discontinuation may increase the risk of symptom recurrence or withdrawal effects. Always seek medical advice before making any changes to your medication.\n\nIs OLANZPRIME 2.5 appropriate for older adults?\n\nHealthcare professionals may prescribe this medicine for elderly patients when clinically appropriate. Individual dosage adjustments may be necessary depending on the patient's overall health and medical history.\n\nHow long should treatment continue?\n\nThe duration of therapy varies according to the patient's diagnosis, treatment response, and clinical condition. Your healthcare provider will determine the most appropriate treatment plan and monitor progress throughout therapy.", "price": 60.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2489, "imageuri": "https://productimages.withfloats.com/actual/6a6deddbc0246085c8f7252b.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a6deddbc0246085c8f7252b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-01T13:00:08.65Z", "updatedon": "2026-08-01T13:00:08.65Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-2-5-mg/2489", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OLANZPRIME 2.5", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a6dec4d7747964c2eea9a0f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Metoprolol Succinate & Hydrochlorthiazide Extended Release Tablets", "description": "METAPROLATE H 50/12.5 is a premium antihypertensive medication formulated with Metoprolol Succinate Extended Release 50 mg and Hydrochlorothiazide 12.5 mg. This dual-action combination is intended for the treatment of hypertension (high blood pressure) in adults who require combination therapy for better blood pressure control. By combining two well-established medicines with complementary mechanisms of action, the formulation helps support long-term cardiovascular health while offering the convenience of once-daily dosing.\n\nManufactured in GMP-certified facilities using high-quality pharmaceutical ingredients, METAPROLATE H 50/12.5 is produced under rigorous quality assurance protocols to ensure safety, efficacy, and batch-to-batch consistency. The extended-release technology allows a gradual release of Metoprolol throughout the day, providing sustained therapeutic effects and helping maintain stable blood pressure levels.\n\nComposition\n\nBrand Name: METAPROLATE H 50/12.5\n\nGeneric Name: Metoprolol Succinate Extended Release & Hydrochlorothiazide Tablets\n\nEach Extended Release Tablet Contains:\n\nMetoprolol Succinate Extended Release – 50 mg\nHydrochlorothiazide – 12.5 mg\n\nDosage Form: Extended Release Tablets\n\nTherapeutic Category: Antihypertensive Medication\n\nWhat is METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 combines a beta-blocker and a thiazide diuretic to provide comprehensive blood pressure management.\n\nMetoprolol Succinate selectively blocks beta-1 receptors in the heart, reducing heart rate and decreasing the workload on the cardiovascular system. Hydrochlorothiazide acts as a diuretic by helping the body eliminate excess sodium and water through urine, lowering blood volume and contributing to reduced blood pressure.\n\nTogether, these medicines offer a complementary approach to hypertension treatment and may help lower the risk of complications associated with persistently elevated blood pressure, including stroke, heart attack, and kidney damage, when used according to medical advice.\n\nUses of METAPROLATE H 50/12.5\n\nHealthcare professionals may prescribe METAPROLATE H 50/12.5 for:\n\nManagement of essential hypertension\nPatients requiring combination antihypertensive therapy\nLong-term maintenance of healthy blood pressure levels\nReducing cardiovascular risks associated with uncontrolled hypertension\nSupporting comprehensive blood pressure management alongside lifestyle modifications\n\nThis medicine should always be used under the supervision of a qualified healthcare professional.\n\nBenefits of METAPROLATE H 50/12.5\nDual-Action Blood Pressure Control\n\nThe combination of Metoprolol Succinate and Hydrochlorothiazide addresses hypertension through two different therapeutic pathways, providing effective blood pressure reduction.\n\nSustained Drug Release\n\nThe extended-release formulation delivers Metoprolol gradually over 24 hours, helping maintain stable therapeutic levels and consistent blood pressure control.\n\nConvenient Once-Daily Administration\n\nA single daily dose simplifies long-term treatment and may improve patient adherence to prescribed therapy.\n\nSupports Cardiovascular Health\n\nMaintaining optimal blood pressure with appropriate treatment can help reduce the likelihood of serious cardiovascular complications over time.\n\nManufactured to High Quality Standards\n\nEvery batch is produced using premium pharmaceutical ingredients under strict GMP guidelines, ensuring reliable quality, safety, and consistency.\n\nHow METAPROLATE H 50/12.5 Works\n\nThe effectiveness of METAPROLATE H 50/12.5 is based on the complementary actions of its two active ingredients.\n\nMetoprolol Succinate works by selectively blocking beta-1 adrenergic receptors in the heart, which helps:\n\nSlow the heart rate\nReduce the force of cardiac contractions\nDecrease oxygen demand by the heart\nLower blood pressure\n\nHydrochlorothiazide works by promoting the removal of excess salt and water from the body through the kidneys. This helps:\n\nReduce circulating blood volume\nMinimize fluid retention\nLower blood pressure\nImprove overall cardiovascular function\n\nTogether, these mechanisms contribute to effective and sustained blood pressure management.\n\nDosage and Administration\n\nTake METAPROLATE H 50/12.5 exactly as prescribed by your physician.\n\nGeneral recommendations include:\n\nTake one tablet daily or as directed by your healthcare provider.\nSwallow the extended-release tablet whole with water.\nDo not crush, chew, or split the tablet unless specifically instructed.\nIt may be taken with or without food according to your doctor's advice.\nTake the medication at the same time each day to maintain consistent therapeutic levels.\nContinue treatment as prescribed, even if your blood pressure is well controlled, unless your doctor advises otherwise.\nPossible Side Effects\n\nAs with any prescription medicine, some individuals may experience side effects, although many people tolerate the medication well.\n\nCommonly reported side effects include:\n\nDizziness\nTiredness or fatigue\nSlow heartbeat\nHeadache\nIncreased urination\nNausea\nLow blood pressure\nChanges in electrolyte levels\n\nSeek immediate medical attention if you experience severe allergic reactions, breathing difficulties, fainting, persistent chest pain, or any other serious symptoms.\n\nConsult your healthcare provider if any side effect persists or becomes troublesome.\n\nPrecautions and Warnings\n\nBefore starting METAPROLATE H 50/12.5, inform your healthcare provider if you have:\n\nHeart rhythm abnormalities\nHeart failure\nAsthma or chronic respiratory disorders\nDiabetes mellitus\nKidney or liver impairment\nGout\nElectrolyte imbalance\nThyroid disorders\nAllergy to Metoprolol, Hydrochlorothiazide, sulfonamide-derived medicines, or any ingredient in this product\n\nRegular monitoring of blood pressure, heart rate, kidney function, and electrolyte levels may be recommended during treatment.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from excessive heat, moisture, and direct sunlight.\nKeep the tablets in their original packaging until use.\nStore at the temperature indicated on the product label.\nKeep out of the reach of children.\nWhy Choose METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 is formulated to provide dependable blood pressure management with the convenience of a once-daily extended-release dosage form. Manufactured according to stringent pharmaceutical quality standards, it combines two trusted antihypertensive agents in a single tablet, supporting improved treatment adherence and long-term cardiovascular care.\n\nKey Advantages\n\nExtended-release formulation for sustained therapeutic action\nCombination of two proven antihypertensive medicines\nConvenient once-daily dosing\nHigh-quality manufacturing with strict quality assurance\nReliable efficacy and consistent product performance\nSuitable for long-term hypertension management under medical supervision\nFrequently Asked Questions (FAQs)\nWhat is METAPROLATE H 50/12.5 prescribed for?\n\nIt is prescribed for the treatment of high blood pressure in adults who require combination antihypertensive therapy.\n\nHow does the extended-release formulation benefit patients?\n\nThe extended-release technology gradually releases Metoprolol throughout the day, helping maintain consistent blood levels and prolonged blood pressure control.\n\nCan I discontinue METAPROLATE H 50/12.5 on my own?\n\nNo. Beta-blockers should not be stopped suddenly, as abrupt discontinuation may increase cardiovascular risk. Always consult your healthcare provider before making any changes to your treatment.\n\nCan this medicine be used with other antihypertensive medications?\n\nYour doctor will determine whether additional blood pressure medicines are necessary based on your medical condition and treatment goals.\n\nHow long should treatment continue?\n\nHypertension is often a lifelong condition requiring continuous management. Continue taking METAPROLATE H 50/12.5 for the duration recommended by your healthcare professional, along with appropriate lifestyle modifications and regular medical follow-up.", "price": 248.0, "discountamount": 75.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2488, "imageuri": "https://productimages.withfloats.com/actual/6a6dec4fc0246085c8f72513.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a6dec4fc0246085c8f72513.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-01T12:53:33.409Z", "updatedon": "2026-08-01T12:53:33.409Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metoprolol-succinate-hydrochlorthiazide-extended-release-tablets/2488", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPROLATE H 50/12.5", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a685f3a5315456e18559082", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Acebrophylline and Erdosteine Tablets", "description": "Acebrophylline and Erdosteine Tablets are a clinically trusted combination used in the management of chronic respiratory disorders associated with excessive mucus production, airway inflammation, and breathing difficulties. This dual-action formulation combines the bronchodilator and anti-inflammatory properties of Acebrophylline with the mucolytic and antioxidant benefits of Erdosteine, making it an effective treatment option for patients suffering from chronic obstructive pulmonary disease (COPD), chronic bronchitis, bronchial asthma, and other mucus-related respiratory conditions.\n\nAt [Your Company Name], we manufacture and supply premium-quality Acebrophylline and Erdosteine Tablets that comply with WHO-GMP standards and international pharmaceutical quality guidelines. Our formulations are trusted by healthcare professionals, hospitals, distributors, and pharmaceutical companies seeking reliable respiratory medicines.\n\nComposition\nEach film-coated tablet typically contains:\n\nAcebrophylline – 200 mg\nErdosteine – 300 mg\nComposition can be customized based on customer requirements and regulatory approvals.\n\nHow Acebrophylline and Erdosteine Tablets Work\nThe combination provides comprehensive respiratory support through complementary mechanisms.\n\nAcebrophylline\nAcebrophylline acts as a bronchodilator and anti-inflammatory agent. It helps relax bronchial muscles, widens the airways, improves airflow, and reduces inflammation, making breathing easier for patients with chronic respiratory diseases.\n\nErdosteine\nErdosteine is a powerful mucolytic agent that reduces the thickness and stickiness of mucus. It facilitates easier expectoration, reduces coughing, and provides antioxidant protection against airway damage caused by inflammation.\n\nTogether, these ingredients improve lung function, reduce respiratory symptoms, and enhance patient comfort.\n\nKey Benefits of Acebrophylline and Erdosteine Tablets\nHelps improve breathing by relaxing bronchial muscles\nEffectively reduces thick mucus accumulation\nSupports easier mucus clearance from the lungs\nReduces chronic cough and chest congestion\nHelps manage COPD and chronic bronchitis symptoms\nProvides antioxidant protection to respiratory tissues\nImproves oxygen exchange and lung function\nEnhances quality of life in patients with chronic respiratory disorders\nSuitable for long-term respiratory disease management under medical supervision\nMedical Uses of Acebrophylline and Erdosteine Tablets\nHealthcare professionals commonly prescribe Acebrophylline and Erdosteine Tablets for:\n\nChronic Obstructive Pulmonary Disease (COPD)\nChronic Bronchitis\nBronchial Asthma\nRespiratory Tract Infections with Excessive Mucus\nChronic Productive Cough\nAirway Inflammation\nBronchiectasis\nSmoking-related Respiratory Conditions\nThese tablets should always be used under the supervision of a qualified healthcare professional.\n\nAdvantages of the Acebrophylline and Erdosteine Combination\nThe combination therapy offers several clinical advantages over single-drug treatment.\n\nDual Mechanism of Action\nIt simultaneously opens the airways while reducing mucus thickness, providing comprehensive respiratory relief.\n\nImproved Lung Function\nPatients experience better airflow and enhanced breathing comfort due to bronchodilation and mucus clearance.\n\nReduced Frequency of Exacerbations\nRegular use, as prescribed, may help decrease episodes of worsening respiratory symptoms in chronic lung diseases.\n\nBetter Patient Compliance\nA fixed-dose combination simplifies treatment by reducing the need for multiple medications.\n\nRecommended Dosage\nThe dosage of Acebrophylline and Erdosteine Tablets should be determined by a registered healthcare provider based on the patient's age, condition, and medical history.\n\nGeneral recommendations include:\n\nTake the tablet after meals with water.\nSwallow whole without crushing or chewing.\nFollow the prescribed duration of therapy.\nDo not exceed the recommended dose.\nPossible Side Effects\nLike all medicines, Acebrophylline and Erdosteine Tablets may cause side effects in some individuals.\n\nCommon side effects include:\n\nNausea\nStomach discomfort\nHeadache\nDizziness\nMild diarrhea\nDry mouth\nGastric irritation\nSeek immediate medical attention if severe allergic reactions, breathing difficulty, or persistent adverse effects occur.\n\nPrecautions\nBefore using Acebrophylline and Erdosteine Tablets, patients should inform their healthcare provider if they have:\n\nLiver disease\nKidney impairment\nGastric ulcer\nHeart disease\nPregnancy or breastfeeding\nKnown allergy to methylxanthines or Erdosteine\nAvoid self-medication and always follow professional medical advice.\n\nStorage Instructions\nStore below 25°C in a cool and dry place.\nProtect from direct sunlight and moisture.\nKeep out of reach of children.\nDo not use after the expiry date.\nWhy Choose Our Acebrophylline and Erdosteine Tablets?\nWe are committed to delivering pharmaceutical products that meet international quality standards.\n\nOur advantages include:\n\nWHO-GMP Certified Manufacturing\nISO Certified Production Facilities\nStringent Quality Control\nDCGI-Compliant Manufacturing\nCompetitive Pricing\nBulk Supply Capability\nThird-Party Manufacturing Services\nPrivate Label Packaging\nTimely Global Deliveries\nCustom Packaging Solutions\nWe serve pharmaceutical distributors, hospitals, government tenders, exporters, wholesalers, and healthcare institutions worldwide.\n\nFrequently Asked Questions (FAQs)\n1. What are Acebrophylline and Erdosteine Tablets used for?\nAcebrophylline and Erdosteine Tablets are primarily used to treat respiratory conditions such as COPD, chronic bronchitis, asthma, and other diseases associated with excessive mucus production and airway obstruction.\n\n2. How do Acebrophylline and Erdosteine Tablets work?\nAcebrophylline relaxes the bronchial muscles and reduces inflammation, while Erdosteine breaks down thick mucus, making it easier to remove from the lungs.\n\n3. Can Acebrophylline and Erdosteine Tablets treat chronic cough?\nYes. These tablets help relieve chronic productive cough by reducing mucus viscosity and improving airway clearance when prescribed by a healthcare professional.\n\n4. Are Acebrophylline and Erdosteine Tablets safe for long-term use?\nThey may be prescribed for long-term management of chronic respiratory diseases, but treatment duration should always be determined by a physician.\n\n5. Can these tablets be used for asthma?\nYes. Doctors may prescribe Acebrophylline and Erdosteine Tablets as part of asthma management when mucus accumulation and airway inflammation are significant.\n\n6. Do Acebrophylline and Erdosteine Tablets have side effects?\nMost side effects are mild and temporary, including nausea, headache, dizziness, stomach upset, and dry mouth. Serious reactions are uncommon but require immediate medical attention.\n\n7. Should Acebrophylline and Erdosteine Tablets be taken before or after food?\nThey are generally recommended after meals to reduce the risk of stomach irritation. Follow your doctor's advice regarding dosage and timing.\n\n8. Can smokers use Acebrophylline and Erdosteine Tablets?\nYes. Physicians often prescribe them to smokers suffering from chronic bronchitis, COPD, or mucus-related respiratory disorders.\n\n9. Are Acebrophylline and Erdosteine Tablets available for third-party manufacturing?\nYes. We offer third-party manufacturing, private labeling, customized packaging, and bulk pharmaceutical supply for domestic and international markets.\n\n10. Why buy Acebrophylline and Erdosteine Tablets from us?\nOur products are manufactured in WHO-GMP-certified facilities using premium-quality raw materials, strict quality control processes, competitive pricing, and reliable global distribution, making us a trusted pharmaceutical manufacturing partner.\n\nThis version is optimized for buyer intent, includes keyword-rich headings and FAQs designed for Google Search and voice search, and naturally targets the primary keyword “Acebrophylline and Erdosteine Tablets” throughout the content without excessive keyword stuffing.", "price": 360.0, "discountamount": 108.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2487, "imageuri": "https://productimages.withfloats.com/actual/6a685f3db435445dbdc3d469.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a685f3db435445dbdc3d469.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-28T07:50:18.551Z", "updatedon": "2026-07-28T07:50:18.551Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//acebrophylline-and-erdosteine-tablets/2487", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "STERIPHYLLIN ERDO", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a685b1d4a217a55d42919c1", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Moxifloxacin & Dexamethasone Eye Drops", "description": "Buy Moxifloxacin & Dexamethasone Eye Drops Online at the Best Price\nMoxifloxacin & Dexamethasone Eye Drops are a prescription ophthalmic medication formulated to treat bacterial eye infections accompanied by inflammation. This dual-action eye drop combines Moxifloxacin, a broad-spectrum fluoroquinolone antibiotic, and Dexamethasone, a corticosteroid that helps reduce redness, swelling, pain, and irritation.\n\nIf you are experiencing symptoms such as red eyes, bacterial conjunctivitis, post-operative eye inflammation, or other bacterial eye conditions, Moxifloxacin & Dexamethasone Eye Drops offer effective treatment by eliminating infection while controlling inflammation.\n\nOrder genuine Moxifloxacin & Dexamethasone Eye Drops online from our trusted pharmacy with competitive pricing, secure payment options, and fast worldwide delivery.\n\nWhat Are Moxifloxacin & Dexamethasone Eye Drops?\nMoxifloxacin & Dexamethasone Eye Drops are a combination ophthalmic solution prescribed by eye specialists for treating bacterial infections of the eye where inflammation is also present.\n\nActive Ingredients\nMoxifloxacin: A fourth-generation fluoroquinolone antibiotic that stops bacterial growth by inhibiting DNA replication.\nDexamethasone: A potent corticosteroid that reduces inflammation, swelling, redness, itching, and discomfort.\nTogether, these ingredients provide comprehensive treatment by fighting bacteria while relieving inflammatory symptoms.\n\nUses of Moxifloxacin & Dexamethasone Eye Drops\nDoctors commonly prescribe these eye drops for:\n\nBacterial conjunctivitis (Pink Eye)\nBlepharitis\nKeratitis\nCorneal bacterial infections\nPost-operative eye inflammation\nEye infections after cataract surgery\nInflammatory bacterial eye conditions\nPrevention of infection following certain eye procedures\nNote: These eye drops are effective only against bacterial infections and should not be used for viral or fungal eye infections unless advised by an ophthalmologist.\n\nBenefits of Moxifloxacin & Dexamethasone Eye Drops\nChoosing this combination medication provides several advantages:\n\nTreats bacterial infection effectively\nReduces eye redness and swelling\nRelieves pain and irritation\nSpeeds recovery after eye surgery\nHelps prevent complications\nBroad-spectrum antibacterial coverage\nConvenient combination therapy in one bottle\nHow Moxifloxacin & Dexamethasone Eye Drops Work\nThis medication works through a dual mechanism.\n\nMoxifloxacin\nMoxifloxacin blocks bacterial enzymes called DNA gyrase and topoisomerase IV, preventing bacteria from multiplying and ultimately eliminating the infection.\n\nDexamethasone\nDexamethasone suppresses inflammatory chemicals produced by the body's immune response, reducing:\n\nSwelling\nRedness\nPain\nEye irritation\nWatering\nTogether, these ingredients provide faster symptom relief while addressing the underlying bacterial infection.\n\nHow to Use Moxifloxacin & Dexamethasone Eye Drops\nFor the best results:\n\nWash your hands thoroughly.\nShake the bottle if instructed.\nTilt your head back.\nPull down the lower eyelid.\nInstill the prescribed number of drops.\nClose your eye gently for 1–2 minutes.\nAvoid touching the dropper tip to any surface.\nAlways follow your eye doctor's prescribed dosage and complete the full treatment course.\n\nRecommended Dosage\nThe dosage depends on:\n\nSeverity of infection\nPatient's age\nMedical history\nDoctor's recommendation\nTypically, patients are advised to use 1–2 drops in the affected eye several times daily, but dosage varies according to individual treatment plans.\n\nNever stop using the medication early even if symptoms improve.\n\nPossible Side Effects\nLike all medications, Moxifloxacin & Dexamethasone Eye Drops may cause mild side effects.\n\nCommon side effects include:\n\nTemporary burning sensation\nEye irritation\nMild blurred vision\nWatery eyes\nDry eyes\nItching\nEye discomfort\nRare but serious side effects include:\n\nAllergic reactions\nIncreased eye pressure\nVision changes\nPersistent eye pain\nSecondary eye infections\nSeek immediate medical attention if severe reactions occur.\n\nPrecautions Before Using\nInform your doctor if you have:\n\nGlaucoma\nViral eye infections\nFungal eye disease\nEye injury\nAllergies to fluoroquinolone antibiotics\nPregnancy or breastfeeding\nAvoid wearing contact lenses during active eye infection unless your doctor approves.\n\nDo not share eye drops with others.\n\nStorage Instructions\nStore the eye drops:\n\nAt room temperature\nAway from direct sunlight\nKeep bottle tightly closed\nProtect from moisture\nKeep out of children's reach\nDiscard the bottle after the recommended period once opened.\n\nWhy Buy Moxifloxacin & Dexamethasone Eye Drops From Us?\nWhen purchasing from our online pharmacy, you receive:\n\nGenuine pharmaceutical products\nAffordable prices\nSecure online ordering\nWorldwide shipping\nSafe packaging\nReliable customer support\nFast order processing\nQuality assurance\nWe prioritize customer safety by supplying onlyThey are used to treat bacterial eye infections while reducing inflammation, redness, pain, and swelling caused by the infection authentic medications sourced from trusted manufacturers.\n\nFrequently Asked Questions (Google & Voice Search Optimized)\nWhat are Moxifloxacin & Dexamethasone Eye Drops used for?\nThey are used to treat bacterial eye infections while reducing inflammation, redness, pain, and swelling caused by the infection or after eye surgery.\n\nAre Moxifloxacin & Dexamethasone Eye Drops antibiotics?\nYes. Moxifloxacin is an antibiotic that kills bacteria, while Dexamethasone is a corticosteroid that reduces inflammation.\n\nHow long do Moxifloxacin & Dexamethasone Eye Drops take to work?\nMany patients notice symptom improvement within 24–48 hours, although the complete treatment course should always be finished as prescribed.\n\nCan I use Moxifloxacin & Dexamethasone Eye Drops for pink eye?\nYes, they are commonly prescribed for bacterial conjunctivitis (pink eye). They are not effective for viral or allergic conjunctivitis unless specifically recommended by a doctor.\n\nCan these eye drops treat viral eye infections?\nNo. They are intended for bacterial infections and should not be used for viral eye infections without medical supervision.\n\nIs a prescription required for Moxifloxacin & Dexamethasone Eye Drops?\nYes. These are prescription medications and should only be used under the guidance of a qualified healthcare professional.\n\nCan I wear contact lenses while using these eye drops?\nIt is generally recommended to avoid wearing contact lenses during treatment for an active bacterial eye infection unless your eye doctor advises otherwise.\n\nHow often should I use Moxifloxacin & Dexamethasone Eye Drops?\nFollow your doctor's prescribed schedule. The frequency depends on the severity of your eye infection.\n\nWhat should I do if I miss a dose?\nUse the missed dose as soon as you remember. If it is nearly time for the next scheduled dose, skip the missed one and continue your normal dosing schedule. Do not use a double dose.\n\nCan children use Moxifloxacin & Dexamethasone Eye Drops?\nThey may be prescribed for children in certain cases, but only under the supervision of a qualified healthcare provider.\n\nAre there any side effects?\nSome people experience temporary burning, mild irritation, blurred vision, or watery eyes. Serious side effects are uncommon but require prompt medical attention.\n\nCan I drive after using the eye drops?\nTemporary blurred vision may occur immediately after application. Wait until your vision clears before driving or operating machinery.\n\nHow should I store Moxifloxacin & Dexamethasone Eye Drops?\nStore them at room temperature, away from heat, moisture, and direct sunlight. Keep the bottle tightly closed when not in use.\n\nCan I stop using the eye drops when my eyes feel better?\nNo. Complete the entire prescribed course even if symptoms improve to help ensure the infection is fully treated and reduce the risk of recurrence.\n\nWhere can I buy genuine Moxifloxacin & Dexamethasone Eye Drops online?\nYou can purchase authentic Moxifloxacin & Dexamethasone Eye Drops from a reputable licensed online pharmacy that offers genuine products, secure payments, and reliable shipping. Always ensure a valid prescription is provided where required.\n\nSEO Meta Title (60 characters):\nMoxifloxacin & Dexamethasone Eye Drops | Buy Online\n\nSEO Meta Description (160 characters):\nBuy Moxifloxacin & Dexamethasone Eye Drops online for bacterial eye infections and inflammation. Genuine medicine, affordable price, fast worldwide delivery.\n\nSEO URL Slug:\n/moxifloxacin-dexamethasone-eye-drops\n\nPrimary Keyword:\nMoxifloxacin & Dexamethasone Eye Drops\n\nRelated SEO Keywords:\n\nBuy Moxifloxacin & Dexamethasone Eye Drops\nMoxifloxacin Eye Drops\nDexamethasone Eye Drops\nAntibiotic Eye Drops\nEye Infection Treatment\nEye Drops for Bacterial Conjunctivitis\nPrescription Eye Drops\nPost Eye Surgery Eye Drops\nMoxifloxacin Dexamethasone Ophthalmic Solution\nEye Drops for Eye Infection\n", "price": 93.0, "discountamount": 28.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2486, "imageuri": "https://productimages.withfloats.com/actual/6a685b1fc40233ec38db8d0d.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a685b1fc40233ec38db8d0d.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-28T07:32:45.398Z", "updatedon": "2026-07-28T08:54:07.586Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//moxifloxacin-dexamethasone-eye-drops/2486", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION MOXDEX", "category": "Opthalmology Range", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }